Budget Amount *help |
¥16,770,000 (Direct Cost: ¥12,900,000、Indirect Cost: ¥3,870,000)
Fiscal Year 2016: ¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2015: ¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2014: ¥7,930,000 (Direct Cost: ¥6,100,000、Indirect Cost: ¥1,830,000)
|
Outline of Final Research Achievements |
We have performed genetic testing in patients with RASopathies and successfully identified a new gene, RIT1, in patients with Noonan syndrome. In this study, we further analyzed clinical manifestations in RIT1 mutation-positive patients and performed functional analysis in cell culture system. We developed comprehensive analysis system using a next generation sequencer to analyze genes for RASopathies. We successfully generated model mice for CFC syndrome. The results would lead to the understanding of the pathogenesis of these disorders and the development of therapeutic means.
|